Literature DB >> 31494797

In Vitro Angiogenic Properties of Plasmid DNA Encoding SDF-1α and VEGF165 Genes.

Valeriya V Solovyeva1, Daria S Chulpanova1, Leysan G Tazetdinova1, Ilnur I Salafutdinov1, Ilia Y Bozo2,3, Artur A Isaev4, Roman V Deev5, Albert A Rizvanov6.   

Abstract

The stromal-derived factor-1 alpha (SDF-1α) and vascular endothelial growth factor (VEGF) play an important role in angiogenesis and exert a significant trophic function. SDF-1α is a chemoattractant for endothelial progenitor cells derived from bone marrow and promotes new blood vessel formation. VEGF regulates all types of vascular growth, stimulates angiogenesis, and is involved in the induction of lymphangiogenesis. The possibility of using these growth factors for regenerative medicine is currently under investigation. The angiogenic potential of a pBud-SDF-1α-VEGF165 bicistronic plasmid construct which simultaneously encodes VEGF165 and SDF-1α genes cDNA was evaluated in this study. The conditioned medium collected from HEK293T cells transfected with the pBud-SDF-1α-VEGF165 plasmid was shown to stimulate the formation of capillary-like structures by human umbilical vein-derived endothelial cells (HUVEC) on Matrigel and to increase the proliferative activity of these cells in vitro. Thus, the pBud-SDF-1α-VEGF165 plasmid exhibits angiogenic properties in cell cultures in vitro. As interest in the development of non-viral techniques for regenerative medicine increases, this plasmid which simultaneously expresses VEGF165 and SDF-1α may provide a platform for advanced methods of stimulating therapeutic angiogenesis.

Entities:  

Keywords:  Angiogenesis; Endothelial cells; Genetic modification; Mesenchymal stem cells; Stromal-derived factor; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2019        PMID: 31494797     DOI: 10.1007/s12010-019-03128-5

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  4 in total

Review 1.  Production and Application of Multicistronic Constructs for Various Human Disease Therapies.

Authors:  Alisa A Shaimardanova; Kristina V Kitaeva; Ilmira I Abdrakhmanova; Vladislav M Chernov; Catrin S Rutland; Albert A Rizvanov; Daria S Chulpanova; Valeriya V Solovyeva
Journal:  Pharmaceutics       Date:  2019-11-06       Impact factor: 6.321

2.  Angiogenesis and nerve regeneration induced by local administration of plasmid pBud-coVEGF165-coFGF2 into the intact rat sciatic nerve.

Authors:  Ruslan Masgutov; Alina Zeinalova; Alexey Bogov; Galina Masgutova; Ilnur Salafutdinov; Ekaterina Garanina; Valeriia Syromiatnikova; Kamilla Idrisova; Adelya Mullakhmetova; Dina Andreeva; Liliya Mukhametova; Adilet Kadyrov; Igor Pankov; Albert Rizvanov
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

3.  Proangiogenic Effect of 2A-Peptide Based Multicistronic Recombinant Constructs Encoding VEGF and FGF2 Growth Factors.

Authors:  Dilara Z Gatina; Ekaterina E Garanina; Margarita N Zhuravleva; Gulnaz E Synbulatova; Adelya F Mullakhmetova; Valeriya V Solovyeva; Andrey P Kiyasov; Catrin S Rutland; Albert A Rizvanov; Ilnur I Salafutdinov
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

4.  VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice.

Authors:  Ying Sun; Tao Wang; Qi-Tao Wen; Da-Hai Yu; Jing-Xin Chen
Journal:  Ann Transl Med       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.